Molecular Mechanism and Rationale This therapeutic mechanism centers on a distinct circuit-RNA regulatory network that integrates theta-alpha oscillation dynamics (4-12 Hz) with mitochondrial biogenesis-mediated neuroprotection through somatostatin (SST) interneuron-specific long non-coding RNA networks. The hypothesis posits that closed-loop transcranial focused ultrasound (cl-tFUS) selectively activates hippocampal SST interneurons, which constitute approximately 30-35% of GABAergic interneurons and serve as primary generators of theta-alpha oscillations.
...No AI visual card yet
Curated pathway diagram from expert analysis
flowchart TD
A["PV Interneuron Loss
AD Hippocampus/Cortex"]
B["Reduced Perisomatic
Inhibition"]
C["Gamma Oscillation
Disruption 30-80 Hz"]
D["Pyramidal Neuron
Hyperexcitability"]
E["Glutamate Release
Excitotoxicity"]
F["Memory Encoding
Network Failure"]
G["KCNQ2/3 Activation
Restore Inhibition"]
A --> B
B --> C
C --> D
D --> E
E --> F
G -.->|"therapeutic"| C
style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
Median TPM across 13 brain regions for SST, CREB1, lncRNA-9969, PGC1A, TFAM from GTEx v10.
1. Biomarker-Treatment Coupling
Plasma p-tau217 emerges as an ideal trigger because it reflects cerebral tau pathology burden and blood-brain barrier (BBB) permeability dynamics. Elevated p-tau217 correlates with increased exosome CNS penetration through disrupted endothelial junctions and activated transport mechanisms. This creates a self-optimizing therapeutic window where treatment delivery coincides with maximum target accessibility.
**2. lncRNA-0021 Mechanism of Ac
The hypothesis's most glaring weakness is the undefined nature of lncRNA-0021. No sequence accession, genomic coordinates, or functional characterization is provided. Without molecular identity, the therapeutic target cannot be validated, and reproducibility becomes impossible. The cited "emerging lncRNA biology" is insufficient—mechanistic proposals for tau phosphorylation regulation and NF-κB modulation require specific, testable molecular interactions that remain entirely specul
lncRNA-0021 lacks molecular identity—no accession number, sequence, or genomic coordinates provided. This is a fundamental reproducibility failure. Without defined chemistry, you cannot develop SAR, conduct PK/PD studies, or file IP. lncRNA targeting generally requires modified oligonucleotides (ASOs, siRNA) with significant delivery barriers. hUC-MSC exosomes as carriers add another undefined layer: cargo loading efficiency, batch variability, and targeting ligand incorporat
{"hypothesis_title": "Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-0021 Therapeutic Window in AD","synthesis_summary": "This hypothesis proposes an elegant biomarker-triggered therapeutic approach coupling plasma p-tau217 dynamics to exosome-mediated lncRNA-0021 delivery in Alzheimer's disease. While the concept of biomarker-guided dosing to exploit disease-related BBB permeability changes is mechanistically attractive, the fundamental absence of molecular identity for lncRNA-0021 renders the entire therapeutic strategy non-actionable. The undefined nature of the therapeutic tar
No price history recorded yet
Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.
No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.
Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.
High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.
Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.
Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.
Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.
No DepMap CRISPR Chronos data found for SST, CREB1, lncRNA-9969, PGC1A, TFAM.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No knowledge graph edges recorded
No comments yet. Be the first to comment!